sunliquid Technology Proven and Ready for Commercial ...
Transcript of sunliquid Technology Proven and Ready for Commercial ...
ABLC 2015 - Washington, DC
Clariant Biotech & Renewables Center
sunliquid® Technology Proven and Ready for Commercial Deployment
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015 2
Employees 2013
18 099
Business Areas
EBITDA 2013 (CHF m)
before exceptionals
14.1%
Net result 2013 (CHF m)
from continuing operations
Sales 2013 (CHF m)
from continuing operations
A globally leading company in specialty chemicals
Clariant focuses on creating value
through innovation and sustainability.
6 076
858 EBITDA margin 2013
before exceptionals
323
4
Corporate Center, Pratteln, Switzerland
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015 3
Clariant worldwide
More than 100 Group
companies worldwide
Over 200
production sites
Represented in
over 60 countries
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015 4
Clariant’s portfolio offers a wide range of specialty chemicals
Care
Chemicals
Catalysis
& Energy
Natural
Resources
Plastics
& Coatings
SALES
(CHF m) 1 561
EBITDA** (CHF m) 263
EBITDA
MARGIN** 16.8%
*Results full year 2013
**Before exceptional items, as reported
SALES
(CHF m) 713
EBITDA** (CHF m) 159
EBITDA
MARGIN** 22.3%
SALES
(CHF m) 1 281
EBITDA** (CHF m) 195
EBITDA
MARGIN** 15.2%
SALES
(CHF m) 2 521
EBITDA** (CHF m) 356
EBITDA
MARGIN** 14.1%
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015 5
Munich & Straubing – the two Biotech & Renewables sites
Munich
Since 2006
95 employees
Main Research & Development Center
Lab and office space: 3,300 m²
Pilot plant since 2009
Straubing
Since 2011
22 employees
sunliquid demonstration plant
Area: 2,500 m²
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015
Clariant’s Biotechnology platform offers holistic solutions for bio-based products and processes
6
System
solutions out of
one hand
Catalysts
Bio-technology
Chemistry & Materials
Process Technology
Strain
collection
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015
Process solutions in the industry are trying to integrate technology from multiple providers
7
System
solutions out of
one hand
Catalysts
Bio-technology
Chemistry & Materials
Process Technology
Strain
collection
Competitor A
Competitor B
Competitor C
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015
With its focus on integration, sunliquid® is designed to achieve optimal efficiency
8
Bio-
technology
Process
Design
Enzymatic hydrolysis
High sugar yields through
feedstock and process-specific
cellulase enzymes
Integrated on-site enzyme
production with biomass as
nutrient source
Standard equipment
Low scale-up risk due to
established equipment
Standard protocols for plant and
equipment operations
Integrated
Technology
Solution
Low OPEX through process design and efficient conversion
Reduced CAPEX risk
Flexible feedstock input and product output
Ethanol Fermentation
High ethanol yields with
proprietary high-end yeast
technology
Simultaneous one-pot C5&C6
fermentation
Energy integration
Side products (e.g., Lignin) as
energy sources
Integration with site-specific energy
infrastructure
Thermal pre-treatment
Chemical-free & low-cost pre-
treatment
Conditions optimized jointly with
enzyme production
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015
Clariant’s chemicals-free pretreatment is flexible and reduces OPEX
9
Clariant’s low-opex pre-treatment
Chemicals-free mild conditions steam-based
pretreatment
‒ Reduced operation cost, no acid or base
required leading to 45% less overall chemical
costs
‒ Reduced health risk from chemicals handling
Optimized conditions for multiple feedstocks
‒ Wheat Straw1
‒ Corn Stover1
‒ Bagasse1
‒ Long list of other feedstock tested in lab and
pilot plant2
Pre-treated raw material used for screening for
optimized enzymes strains
Hardware technology based on standard equipment
from the Paper & Pulp industry
1 Optimized at Clariant’s demonstration plant in Straubing
2 E.g., Cane Straw, woody biomass (hard and soft), empty fruit bunches, risk husks, rice straw, oat hulls, energy crops, etc.
3 Cost of total chemicals required for process (excl. enzyme production) in case pre-treatment with acid vs. chemical-free pretreatment is used
Sugar cane bagasse
Wheat straw
Chemicals-free Acid based
-45%
Overall chemicals cost3
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015
Clariant’s enzymes are high-performing and cost-saving
10
1 Results were performed on chemical-free pre-treated biomass using standard hydrolysis conditions (identical enzyme concentrations)
2 Commercial enzymes from a leading enzyme provider for cellulytic enzymes (externally produced, purified and formulated for shipment)
Commercial
benchmark2
Lower cost
Higher cost
On-site biomass as
nutrient source
Not required,
whole broth used
for hydrolysis
Produced on-site
Standard enzymes
Expensive synthetic
nutrient source
required
Required for
stabilization
Produced off-site,
Transport required
Chemicals and
energy required
Nutrients
Purification
Formulation
Transport
Clariant’s enzymes show better performance
Clariant’s has established the efficient process of
Selection & Optimization & Screening to
develop and the best strain and activities
Clariant’s integrated on-site enzyme production reduces
cost by cutting out required processing steps and transport
Integration also enables feedstock specificity
Self-sufficiency from external supplier and logistics
Clariant’s enzymes perform better… …and reduce cost through integrated on-site production
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015
The sunliquid® demonstration plant
11
Output: 1,000 t/a Ethanol
Location: Straubing, Germany
Operational since July 2012
Feedstock: ~ 4,500 t/a wheat
straw, corn stover or bagasse
Scale-up towards commercial
scale only 50x
Wheat Straw, Corn Stover, and
Sugarcane Bagasse converted
to Ethanol
Commercial-scale design
confirmed
Scale-up experience from pilot
plant and solution finding
sunliquid® demo plant
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015
sunliquid® is being successfully tested as E20 blend
12
Since January 2014, sunliquid®20 is being tested in Mercedes’ fleet
Gasoline-Ethanol blend containing 20% cellulosic ethanol from Clariant’s demonstration plant
Joint Press Announcement on September 23
4% reduction in energy content through increased engine efficiency compared to E10 –> high quality fuel
with high octane!
Particle emissions are decreased by 50%
Advanced and sustainable! High GHG emission savings through cellulosic ethanol
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015 13
For a 50 kt/a plant, a footprint of
approx. 14-18 acres is required
PDP ready for commercial-scale plant
Confidential information
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015
Cellulosic
Ethanol
sunliquid® is the ideal technology platform for highly sustainable bio-based products
14
sunliquid® sunliquid®
Catalytic conversion sunliquid®
Sugar platform standalone
Development opportunities for
biobased products
Extensive know-how in
biocatalysis, strain optimization
and heterogenous catalysis
Biotechnology
Catalytic conversion
Biotechnology Bio-based
chemicals
Catalytic
conversion Cellulosic
Sugars
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015
Clariant sunliquid® cellulosic ethanol links with JV partner Scientific Design
15
Ethanol Ethylene
Key facts about Scientific Design
50:50 Joint Venture between Clariant and SABIC
Licenser of Ethylene Oxide/Ethylene Glycol Technology (SD awarded ~80% of non-captive
licenses since 1980 with 30 licenses since 1990)
Licenser of alcohol dehydration technology (SD awarded two ethanol-to-ethylene and six
ethanol to EO/EG licenses since 2006)
Integration study has been completed between sunliquid technology & SD downstream
conversion to bio-MEG (including site retrofit and capital estimates)
ABLC 2015 - Washington, DC, Clariant Biotech & Renewables Center, 12.03.2015
For further information please contact:
Martin A. Mitchell
Global Business Development Manager
Group Biotechnology, Biofuels & Derivatives
Clariant Corporation
309 Court Avenue
Des Moines, Iowa 50309 USA
Phone: +515 699 8518
E-mail: [email protected]
For more information on sunliquid® technology visit www.sunliquid.com
16